Adverse Drug Reaction Classification System

Pharmaceutical Information
Drug Name Albendazole
Drug ID BADD_D00052
Description A benzimidazole broad-spectrum anthelmintic structurally related to mebendazole that is effective against many diseases. (From Martindale, The Extra Pharmacopoeia, 30th ed, p38)
Indications and Usage For the treatment of parenchymal neurocysticercosis due to active lesions caused by larval forms of the pork tapeworm, Taenia solium and for the treatment of cystic hydatid disease of the liver, lung, and peritoneum, caused by the larval form of the dog tapeworm, Echinococcus granulosus.
Marketing Status Prescription; Discontinued
ATC Code P02CA03
DrugBank ID DB00518
KEGG ID D00134
MeSH ID D015766
PubChem ID 2082
TTD Drug ID D00KVO
NDC Product Code 73309-129; 49452-0003; 63629-1221; 43598-452; 70771-1103; 72205-051; 70710-1021; 16714-907; 42799-110; 31722-935; 69539-151; 69097-237; 72643-008; 0591-2712; 72969-104; 51927-1763; 82195-300; 52286-5500; 51407-258; 64896-693; 0115-1701; 52286-0001; 51927-0068; 60592-002; 69766-026; 53104-7736; 86055-0004; 42291-093; 78482-110
Synonyms Albendazole | Lurdex | Bilutac | Metiazol | Andazol | Albenza | Zentel | Albendoral | Albendazole Monohydrochloride | Monohydrochloride, Albendazole | Bendapar | Digezanol | Disthelm | Mediamix V Disthelm | Endoplus | Eskazole | Gascop | SK&F-62979 | SK&F 62979 | SK&F62979 | SKF-62979 | SKF 62979 | SKF62979 | Valbazen
Chemical Information
Molecular Formula C12H15N3O2S
CAS Registry Number 54965-21-8
SMILES CCCSC1=CC2=C(C=C1)N=C(N2)NC(=O)OC
Chemical Structure
ADR Related Proteins Induced by Drug
ADR Term Protein Name UniProt AC TTD Target ID PMID
Not AvailableNot AvailableNot AvailableNot AvailableNot Available
ADRs Induced by Drug
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Erythema multiforme23.03.01.003; 10.01.03.015--
Fatigue08.01.01.0020.015006%
Gait disturbance17.02.05.016; 08.01.02.0020.015006%
Gastrointestinal pain07.01.05.005--
Generalised oedema14.05.06.007; 08.01.07.0040.007503%
Granulocytopenia01.02.03.003--Not Available
Haemolytic anaemia01.06.03.0020.007503%Not Available
Headache17.14.01.0010.071276%
Hepatitis09.01.07.0040.007503%Not Available
Hepatitis acute09.01.07.0050.007503%Not Available
Hepatocellular injury09.01.07.0080.015006%Not Available
Hyperhidrosis23.02.03.004; 08.01.03.0280.007503%
Hyperpyrexia08.05.02.0020.007503%Not Available
Hypersensitivity10.01.03.003--
Hypotonia17.05.02.002; 15.05.04.0080.007503%Not Available
Immune system disorder10.02.01.001--Not Available
Intracranial pressure increased17.07.02.002--Not Available
Jaundice23.03.03.030; 09.01.01.004; 01.06.04.0040.003914%Not Available
Leukopenia01.02.02.001--Not Available
Lip ulceration07.05.01.0060.007503%Not Available
Liver function test abnormal13.03.01.013--Not Available
Loss of consciousness17.02.04.0040.007503%Not Available
Malaise08.01.01.0030.007503%
Myalgia15.05.02.0010.022508%
Nausea07.01.07.0010.022508%
Neutropenia01.02.03.004--Not Available
Ocular hyperaemia06.04.05.0040.011254%Not Available
Oedema14.05.06.010; 08.01.07.0060.007503%Not Available
Pain in extremity15.03.04.0100.007503%
Pallor24.03.04.001; 23.03.03.031; 08.01.03.0320.011254%Not Available
The 2th Page    First    Pre   2 3 4    Next   Last    Total 4 Pages